Draft Genome Sequence of the Methicillin-Resistant Staphylococcus aureus Isolate MRSA-M2

Area of Science:

• Microbiology
• Genomics
• Infectious Diseases

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing difficult-to-treat infections.
• Osteomyelitis is a serious bone infection often requiring prolonged treatment.
• Understanding MRSA strain characteristics is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To report the draft genome sequence of a specific MRSA clinical isolate, MRSA-M2.
• To provide genomic data for a strain previously used in proteomic, transcriptomic, and animal studies.
• To facilitate further research into MRSA pathogenesis and treatment.

Main Methods:

• Whole-genome sequencing was performed on the MRSA-M2 isolate.
• Bioinformatic analyses were conducted to assemble and annotate the draft genome.
• The strain's characteristics (ST30, spa type T019, agr III) were confirmed.

Main Results:

• The draft genome sequence of MRSA-M2 was successfully generated.
• MRSA-M2 was identified as a sequence type 30 (ST30), spa type T019, agr III strain.
• The genomic data provides a foundation for understanding the strain's biological behavior.

Conclusions:

• The availability of the MRSA-M2 genome sequence enhances its utility as a model organism.
• This genomic resource will aid in comparative genomics and the study of MRSA virulence factors.
• Further research utilizing this strain can contribute to improved diagnostics and treatments for MRSA infections.